← All companies

TLPH

Talphera, Inc.

TLPH Nasdaq Pharmaceutical Preparations EDGAR ↗

$1.33

-0.03 -2.21%

Key statistics

from XBRL data in SEC filings

Market cap

$69.0M

Revenue (TTM)

$1.00K

Net income (TTM)

-$14.3M

EPS (TTM)

$-0.28

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

$3.82M

Total assets

$30.2M

Gross margin

—

52-week range

$0.39 – $1.57

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change; Shareholder vote results Jun 23, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release) May 13, 2026 10-K Fiscal year ended 2025-12-31 Mar 23, 2026 8-K Results of operations (earnings release) Mar 23, 2026 8-K Unregistered sale of equity Mar 16, 2026 8-K Delisting notice or listing-rule failure Mar 13, 2026 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 8-K Director or officer change; Shareholder vote results Oct 24, 2025 8-K Unregistered sale of equity; Other events Oct 22, 2025 8-K Director or officer change Oct 16, 2025 8-K Entered a material agreement; Unregistered sale of equity Sep 10, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Delisting notice or listing-rule failure Jun 5, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 14, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 29, 2025 8-K Entered a material agreement; Unregistered sale of equity Apr 2, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Results of operations (earnings release) Mar 31, 2025 8-K Delisting notice or listing-rule failure Dec 11, 2024 8-K Delisting notice or listing-rule failure Nov 29, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Results of operations (earnings release) Nov 13, 2024 8-K Entered a material agreement Oct 1, 2024 8-K Results of operations (earnings release); Director or officer change Aug 14, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Director or officer change; Shareholder vote results Jun 24, 2024 10-Q Quarter ended 2024-03-31 May 14, 2024 8-K Results of operations (earnings release) May 14, 2024 8-K Item 5.08; Other events Apr 19, 2024 10-K Fiscal year ended 2023-12-31 Mar 6, 2024 8-K Results of operations (earnings release) Mar 6, 2024 8-K Director or officer change; Other events Mar 1, 2024 8-K Entered a material agreement; Results of operations (earnings release); Unregistered sale of equity; Director or officer change; Regulation FD disclosure Jan 22, 2024 8-K Entered a material agreement Jan 18, 2024 8-K Amended charter or bylaws; Regulation FD disclosure Jan 9, 2024 10-Q Quarter ended 2023-09-30 Nov 14, 2023